Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib

Valor-Mendez L, Sticherling M, Kleyer A, Schett G (2021)

Publication Type: Journal article, Letter

Publication year: 2021

Journal

Clinical and Experimental Rheumatology Clinical and Experimental Rheumatology Sas

Book Volume: 39

Pages Range: 228-228

Journal Issue: 1

DOI: 10.55563/clinexprheumatol/xdcraa

Authors with CRIS profile

Michael Sticherling Professur für Dermatologie Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology Georg Schett Lehrstuhl für Innere Medizin III

How to cite

APA:

Valor-Mendez, L., Sticherling, M., Kleyer, A., & Schett, G. (2021). Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib. Clinical and Experimental Rheumatology, 39(1), 228-228. https://dx.doi.org/10.55563/clinexprheumatol/xdcraa

MLA:

Valor-Mendez, Larissa, et al. "Successful treatment of refractory palmoplantar psoriasis in a psoriatic arthritis patient with the JAK inhibitor tofacitinib." Clinical and Experimental Rheumatology 39.1 (2021): 228-228.

BibTeX: Download